



	Questions : Lok Sabha




























Screen Reader Access
Skip to Main Content
Skip to Navigation



Text Size

                                A

                                A
A















हिन्दी मे








Parliament of India Lok Sabha House of the
                        People






* Special Characters not allowed












India Time 


Your Time 


                        Tuesday,
                        12 April 2022









HomeMembersSitting MembersMembers Home PageMembers' PortalContact DetailsMembers SearchStatistical AnalysisAttendance of MembersHandbook Members Since 1952Digitized Who's WhoOthers BusinessProvisional CalendarList of BusinessPapers to be LaidList of Private Members' BusinessBulletin-IDigitized Lok Sabha Bulletin Part IBulletin-IIStatement of WorkSpecial Mentions (ZERO HOUR)Resume of WorkDigitized Resume of Work done by Lok Sabha QuestionsHomeQuestion ListStatus of notices of questionQuestions CalendarGrouping of Ministries - AlphabeticalOfficers in Min./Dept. Dealing with Parliamentary WorkQuestion SearchSupplementary Questions DebatesIntroductionSynopsisUncorrected DebateText of DebateDigitized DebatesConstituent Assembly DebatesWit And HumourDebate SearchHindi FontsDisclaimer Papers LaidPapers Laid on the Table of the House LegislationIntroduction(How Bill Becomes Act)Bills IntroducedBills PassedBills PendingBills AssentedBills LapsedBills WithdrawnBills NegativedBills Search Disclaimer CommitteesIntroductionChairpersonSummary of WorkCommittee Meetings ScheduleBills Referred to CommitteesReports PresentedDigitized ReportsPress ReleaseMembership SearchToday's Committee MeetingsCommittee Subject SelectedDepartment Related-RS Govt. AssurancesSANSAD TVIntranet





HomeQuestion ListStatus of notices of questionQuestions CalendarGrouping of Ministries - AlphabeticalOfficers in Min./Dept. Dealing with Parliamentary WorkQuestion SearchSupplementary Questions











Download as PDF




Print












PDF/WORD(Hindi)


PDF/WORD




                                    GOVERNMENT OF INDIA
                                





                                    MINISTRY OF
                                    CHEMICALS AND FERTILIZERS






                                    LOK SABHA
                                





UNSTARRED 


                                    QUESTION NO:
                                

368






                                    ANSWERED ON: 
                                

20.07.2021






Oral Antiviral Drug




M. K. Raghavan














                        Will the Minister of





CHEMICALS AND FERTILIZERS


                        be pleased to state:-















                                                    Will the Minister of CHEMICALS AND FERTILIZERS be pleased to state: (a) whether the Government is developing any oral antiviral drug to treat COVID; (b) if so, the details including the status of trial runs and its results so far; (c) the details of the firms involved in the manufacture and trial run and the time schedule for licensing and production in this regard; and (d) the details about the expected relief/outcome from oral antiviral against vaccination?






ANSWER




                                                        MINISTER IN THE MINISTRY OF CHEMICALS & FERTILIZERS                                   (SHRI MANSUKH MANDAVIYA)(a)to (c):  Defense Research & Development Organization (DRDO) has informed that they have developed 2DG (2-Deoxy-D-glucose). DRDO along with Dr. Reddy’s laboratory conducted Phase-II and Phase-III trials from Mar 2020 to April 2021. Based on highly significant results of Phase-II and interim analysis of Phase-III, DCGI has granted permission on 1st May 2021 for emergency use of 2DG as adjunct therapy in moderate to severe COVID-19 patients. Complete clinical study report of Phase-III trials in moderate to severe COVID-19 patients is expected to be available by the end of August 2021. Currently, DRDO partnered with Dr. Reddy’s lab for manufacturing and conducting the clinical trials on 2DG in India. However, DRDO has transferred the technology to produce 2DG to 4 more pharma companies. Council of Scientific and Industrial Research (CSIR) has informed that CSIR-Central Drug Research Institute (CSIR-CDRI), a constituent laboratory of Council of Scientific & Industrial Research (CSIR) has developed an oral drug Umifenovir. Its clinical trials have just been completed by CSIR-CDRI. Further, another CSIR constituent laboratory, CSIR-National Institute for Interdisciplinary Science and Technology (CSIR-NIIST) has developed a new process for Molnupiravir, an oral antiviral drug. (d):     As per DRDO, 2DG is effective in COVID patients. This Drug is therapeutic and will be given to infected COVID patients. It is not a vaccinexxxxx
























HomeArchiveIndex to Select Questions (1984-1999)Ballot ListStatistical Statements Relating to QuestionsUploading of Questions - Status QueryProcedure for Sending Text of Questions & AnswersDemarcation of responsibilities in Govt. of IndiaBrochure on Statutory Corporations, Companies and Other Bodies in Which the Government of India have financial or controlling interestHighlights pertaining to questions of 17th Lok Sabha






Contact Us 
Disclaimer











        Developed and Hosted by National Informatics Centre (NIC)

Content on this website is published,
            managed & maintained by Software Unit, Computer (HW & SW) Management. Branch,
            Lok Sabha Secretariat





HomeMembersBusinessQuestionsDebatesPapers Laid


LegislationCommitteesSANSAD TVIntranetSecretariatPRIDE


RecruitmentSC/ST ReservationConferenceParliament Library


About ParliamentPhoto GalleryRelated LinksRTITendersFAQ


SpeakerDy. SpeakerLeader of the HousePanel of ChairpersonsContact UsFeedback


Council of MinistersPublications of MinistriesParliamentry ProceduresJournal of Parliamentary Information
Visitor's Counter:113214238







Copyright
Privacy Policy
Disclaimer
Terms &
                Conditions

                Accessibility Statement
Accessibility
                Options
Feedback
Site Map







